Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

This article is part of the Research TopicThe Role of RNA Regulation in Cancer Pathogenesis and Therapeutic StrategiesView all 3 articles

CircNF1 Promotes Gastric Cancer Metastasis by Stabilizing HMGA2 mRNA through IGF2BP1 Interaction

Provisionally accepted
Yingying  SunYingying Sun1Yanli  GeYanli Ge2Zhiyu  XiaZhiyu Xia2Cheng  GuoCheng Guo3Junjie  ZhangJunjie Zhang2,4*Zhirong  WangZhirong Wang2*Zhe  WangZhe Wang2*
  • 1The Second Hospital of Shandong University, Jinan, China
  • 2Tongji Hospital Affiliated to Tongji University, Shanghai, China
  • 3The East Hospital Affiliated to Tongji University, Shanghai, China
  • 4Xinjiang Medical University Affiliated Second Hospital, Urumqi, China

The final, formatted version of the article will be published soon.

Gastric cancer (GC) is the fifth most common malignancy worldwide, with metastasis being the primary cause of mortality. Although circular RNAs (circRNAs) are implicated in GC pathogenesis, their specific roles in metastasis remain unclear. In this study, we investigated the function and mechanism of circNF1 in GC progression. CircNF1 expression was evaluated in GC tissues and adjacent normal samples using in situ hybridization, and its clinical relevance was analyzed via Cox regression. Functional assays, including transwell migration and metastatic mouse models, demonstrated that circNF1 overexpression enhanced GC cell motility and pulmonary metastases, while its knockdown suppressed these effects. Mechanistically, circNF1 interacted with IGF2BP1 to stabilize HMGA2 mRNA, thereby promoting metastatic progression. Additionally, ZNF460 was identified as a transcriptional activator of the NF1 host gene, upregulating circNF1 biogenesis. Our findings reveal that ZNF460-induced circNF1 drives GC metastasis by forming a scaffold with IGF2BP1 to stabilize HMGA2, highlighting circNF1 as a potential prognostic biomarker and therapeutic target for GC.

Keywords: circNF1, gastric cancer, HMGA2, IGF2BP1, metastasis, ZNF460

Received: 14 Dec 2025; Accepted: 02 Feb 2026.

Copyright: © 2026 Sun, Ge, Xia, Guo, Zhang, Wang and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Junjie Zhang
Zhirong Wang
Zhe Wang

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.